Type | Subsidiary |
---|---|
Industry | Pharmaceuticals |
Founded | 1835 |
Founder | Franz Ludwig Gehe |
Headquarters | Stuttgart, Germany |
Key people |
|
Services | pharmaceutical wholesale and retail |
Revenue | €21.18 billion (FY 2019) [1] |
Number of employees | 36,917 (FY 2019) |
Parent | McKesson Corporation (76%) |
Website | www |
McKesson Europe AG (formerly Celesio AG, previously Gehe AG), with its headquarters in Stuttgart, Germany, is a leading international wholesale and retail company and provider of logistics and services in the pharmaceutical and healthcare sectors. The company had around 37,000 employees at the end of the 2019 financial year (31 March 2019) and is represented in 13 countries in Europe. In the 2019 financial year the company achieved a turnover of EUR 21.18 billion. The majority shareholder of the company is the US-based McKesson Corporation, which holds a share of 77.01%. The remaining 22.99% of shares are available on the open market. Kevin Kettler, a US citizen, has been Chairman of McKesson Europe since 1 November 2018. [2]
The head office is situated at Stockholmer Platz in the new Europaviertel of Stuttgart, next to Stadtbibliothek and Milaneo shopping centre. The company's core business consists of pharmaceutical wholesale and pharmacies. In the pharmaceutical wholesaling sector, McKesson Europe has a market presence in 14 countries. It has a range of services for pharmacists on matters of health, medicines and wellness. An extensive distribution network of more than 134 branches provides deliveries to some 65,000 pharmacies and hospitals.[ citation needed ]
The business is divided into two business areas:
The chemist and paint business Gehe & Co. was founded on 1 May 1835 by Franz Ludwig Gehe in Dresden on Königstraße and opened to the capital market by converting it into a stock corporation on 1 January 1903. In January 1904, the shares were admitted to trading on the stock exchange in Dresden.
In 1909, the company moved to the new location on Leipziger Straße and the trading house in Königstraße was vacated. With capital increases in 1910 and 1912, the financial basis for the establishment and expansion of a German-wide distribution of "drugs and paints, pharmaceutical and chemical products" was created. In 1922, the company founded its first German branch in Stuttgart. After the Second World War, the parent company in Dresden and most of the branches were expropriated. Gehe & Co. AG made a fresh start in West Germany with branches in Stuttgart, Kassel and Sulzbach-Rosenberg.
The Gehe parent company continued to operate in 1947 in Dresden under the name Heilchemie as a publicly owned enterprise and on 1 April 1951 with the nationalised parent company of the pharmaceutical company Dr. Madaus & Co from Radebeul merged to form VEB Arzneimittelwerk Dresden. Haniel took over the majority of the Gehe & Co. AG shares with effect from 1 January 1973. The condition of Haniel was that the GEHE’s management remained in the company, in order to further expand the solid foundation that was established after the war. The name Gehe, known in the pre-war period, was brought to the attention of pharmacists with the revitalised or newly created branches. These branches were formed during the transition to Haniel: Bremen, Hamburg, Kassel, Kelkheim, Landshut, Mühldorf, Munich, Nuremberg, Regensburg and Stuttgart. In 1973, the company achieved a turnover of DM 285 million. Other pharmaceutical wholesalers (Friedrich Schäfer GmbH, Weiterstadt and Kaiserslautern, Wilmaco GmbH, Hamm and Lieser Pharma-GmbH, Duisburg) were brought in to Gehe & Co. AG via the majority shareholder Franz Haniel & Cie.
In 1982, the Haniel Group acquired RUWA Rudloff & Watermann GmbH & Co. KG in Minden, a pharmaceutical wholesale company with a branch in Delmenhorst and integrated it into Gehe. In 1985, the Kaiser + Kraft Group, Stuttgart, a mail-order business for transport, storage, operational facilities and office equipment, was acquired. Until 1992, customers in Germany were supplied from the branches based in Hamburg, Berlin, Haan, Dresden, Stuttgart and Munich. In the following years, the group's trading structure spread across 14 countries in Europe and the USA. With the public offering of TAKKT on 15 September 1999, the spin-off of the Mail Order Division was ended.
In April 2003, the company celebrated its 100th year. On the birthday of the conversion into a joint-stock company, the Annual General Meeting decided to change the name from Gehe AG to Celesio AG, with a majority of 99.98%. Today, the German subsidiary GEHE Pharma Handel still operates under its original name. In April 2007, Celesio announced the acquisition of 90% of the shares in the mail-order pharmacy DocMorris, in order to build up a pharmacy chain across Germany. The acquisition took place in hopes that the third-party ownership ban of the Pharmacies Act would fail, but it was legitimised in May 2009 by the EuGH. For the pharmaceutical wholesaler Gehe, which was also part of the Celesio Group, the acquisition resulted in a loss of customers as pharmacists saw a threat in the chain. DocMorris was now operated as a franchise-like concept, in which pharmacists were allowed to use the DocMorris brand with the payment of a monthly licence fee. As a result, Celesio sold DocMorris in October 2012 to the company Zur Rose AG.
In June 2009, it became known that Celesio had acquired the majority of the largest Brazilian pharmaceutical wholesaler, Panpharma. In April 2012, Panpharma was fully taken over. In February 2016, Celesio agreed to sell its Brazilian business, consisting of Panpharma and Oncoprod, to the holding of the Brazilian pharmaceutical wholesaler, SantaCruz. In September 2013, Celesio sold its subsidiary, Rudolf Spiegel GmbH, to the company WEPA Apothekenbedarf.
On 24 October 2013, the US-based McKesson Corporation announced an agreement to acquire Celesio for EUR 6.1 billion (approx. EUR 23 per share). However, on 13 January 2014, the company reported that McKesson's acquisition of Celesio was unsuccessful, due to the 75% threshold not being reached. At the start of November 2013, the Elliot hedge fund acquired 12.68% of Celesio from Paul Singer, a well-known course of action by him to benefit from takeovers. Following McKesson's failed takeover, Singer increased his direct and indirect stake to around 32%. On 23 January 2014, Haniel took over the share from the Elliott hedge fund and served the 75.99% one day later to McKesson, which meant that the takeover was still a success. Sainsbury’s and Celesio announced the formation of a strategic pharmacy partnership in July 2013, in the course of which McKesson Europe's subsidiary LloydsPharmacy would acquire Sainsbury’s pharmacy business for GBP 125 million. Until 21 September 2015, the company's shares were listed in MDAX. The quotation in the index was removed, due to the change in the stock exchange segment from Prime Standard to the Regulated Unofficial Market. On 12 September 2017, Celesio was renamed McKesson Europe.
On 12 December 2019, McKesson Corporation announced that it planned to bring its German wholesale business (GEHE Pharma Handel GmbH, a subsidiary of McKesson Europe) into a joint venture with Alliance Healthcare Deutschland AG (a subsidiary of Walgreens Boots Alliance). McKesson should hold 30% of the planned joint venture, Walgreens Boots Alliance 70%.
Alliance Healthcare, formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries.
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson had revenues of $238.2 billion in its fiscal year ending March 31, 2021.
Alliance Boots GmbH was a multinational pharmacy-led health and beauty group with corporate headquarters in Bern, Switzerland and operational headquarters in Nottingham and Weybridge, United Kingdom.
LloydsPharmacy is a British pharmacy company, with more than 1,500 pharmacies. It has around 17,000 staff and dispenses over 150 million prescription items annually. It is owned by the German company McKesson Europe, formerly Celesio then GEHE AG, which is in turn owned by the American McKesson Corporation.
Sigma Healthcare Limited is an Australian, ASX-listed company [ASX:SIG] with a focus on the pharmacy industry. In addition to its wholesale and distribution arms, Sigma Healthcare also owns Australian retail pharmacy brands: Amcal, Discount Drug Stores, PharmaSave, WholeLife and Guardian Pharmacies
PHOENIX Pharmahandel GmbH & Co KG, headquartered in Mannheim, Baden-Württemberg, is the largest pharmaceutical wholesaler in Germany, and the second largest in Europe with about 153 distribution centers across the country delivering drugs to some 12,000 independent pharmacies. Its PHOENIX Documentation is an Internet-based archive offering detailed information on drugs, their components, indications, and effects. Formation of Holding company PHOENIX International Beteiligungs GmbH. Phoenix Group is majority owner of the pharmaceutical wholesalers Purus A.S. in the Czech Republic and Tamro in Finland. Phoenix Group itself is majority-owned by pharmaceutical conglomerate Merckle Group.
Australian Pharmaceutical Industries (API) is a health and beauty company in Australia that is involved in pharmaceutical distribution, retailing and manufacturing. API is Australia's largest wholesale distributor of pharmaceutical and allied products. The company is involved in retailing through company-owned stores and franchise operations. API is listed on the Australian Securities Exchange and operates in the retail health and beauty industry under the following brands: Priceline, Priceline Pharmacy, Soul Pattinson and Pharmacist Advice.
Norsk Medisinaldepot AS is a pharmaceutics and healthcare products wholesaler in Norway. It also operates the pharmacy chains Vitusapotek and the franchise chain Ditt Apotek. NMD is part of the Celesio group and has a total of 185 pharmacies in Norway. The company is based in Oslo.
Vitusapotek is a chain of 200 pharmacies in Norway owned and run by Norsk Medisinaldepot, a subsidiary of McKesson Europe. The chain is based in Oslo, and is the second largest in Norway, after Apotek1.
Pharmacies of Norway are dominated by the three large companies Alliance Boots, Apokjeden and Norsk Medisinaldepot. In total there are 606 pharmacies, of which only 16 do not belong to the four dominant chains Apotek 1, Vitusapotek, Boots apotek and Ditt Apotek. 33 pharmacies are state owned as pharmaceutical trusts.
Stada Arzneimittel AG is a pharmaceutical company based in Bad Vilbel, Germany which specializes in the production of generic and over-the-counter drugs. In 2018, revenue totaled €2.33 billion.
Jenapharm is a pharmaceutical company from Jena, Germany. Founded in 1950 in East Germany, the company focused from the beginning on the production and development of steroids. Due to the economic circumstances of the Eastern Bloc, the company initially used a unique process of steroid synthesis starting from hog bile, however this method was abandoned a decade later in favor of total synthesis. Initially the company produced a wide range of generic steroids, including corticosteroids, but later on it focused on anabolic steroids, estrogens and progestins.
Ulf Mark Schneider is a German-American businessman, and the CEO of Nestlé. He is the former CEO of Fresenius, a €28 billion global healthcare group.
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of December 31, 2019, Evotec had a market capitalization of €3.47 billion and a pipeline of more than 100 partnered programs in discovery, pre-clinical development and clinical development.
AAH is a pharmaceutical wholesaler in the United Kingdom. Originally formed in 1892 as a company selling solid fuels in South Wales, it was floated on the stock exchange in 1923. It diversified into pharmaceuticals in the 1970s, and since 1995 it has been a subsidiary of the German company Celesio AG.
Allen John Lloyd is the founder of LloydsPharmacy, a British pharmacy company, with more than 1,600 pharmacies, and around 17,000 staff.
Galenica AG, headquartered in Bern, is an internationally active Swiss pharmaceutical and logistics company group, named after the ancient physician Galenus. It dates back to the 1927 Collaboration Pharmaceutique SA, a purchasing center for pharmaceutical products founded by 16 pharmacists in Clarens. This was renamed to Galenica AG in 1932 and moved from Vaud's Le Châtelard to Bern. The Galenica shares are listed on the SIX Swiss Exchange and are a component of the SMI MID index.
Wörwag Pharma is an independent family-owned pharmaceutical company headquartered in Böblingen, Germany. It was founded in 1971 by Fritz Wörwag, a pharmacist. It sells prescription and over-the-counter preparations as well as food supplements.
Zur Rose Group, headquartered in Frauenfeld, is an active Swiss-based group operating primarily in Europe online pharmacy and pharma wholesaling. Zur Rose Group is the self proclaimed largest e-commerce pharmacy in Europe, operating in Switzerland, Germany, the Netherlands, Spain and France. Its services are offered under different brands in different countries, DocMorris being the most well known one. The Zur Rose Group shares are listed on the SIX Swiss Exchange.
Wikimedia Commons has media related to Celesio . |